“Ventilation Response Imaging (VRI) for Pulmonary Embolism, Utilizing beta-methyl-P-123I-iodophenyl-pentadecomic acid “. Pennsylvania Hospital . Zemevia Pharmaceuticals. Philadelphia, PA. March, 2009
“Parkinsons Progressive Marker Initiative(PPMI) Utilizing Iodine 123-DAT SPECT Scanning”. IRB # 812050. GE Healthcare and Moleculular Neuroimaging,, New Haven,CT. November, 2010
A Phase II Trial of Florpiramine F 18 PET Imaging of β-amyloid in Parkinson’s Disease Patients with Cognitive Impairment”. (Protocol 18F-AV-45-A12)" IRB # 808985. Pennsylvania Hospital and AVID Pharmaceuticals.. July, 2011.